LizarBio Therapeutics

📍 São Paulo, Brazil🗓 Founded 2013👥 5 employees💰 Last funded Dec 2018
Biotechnology Research🌐 lizar.bio
Website LinkedIn
LizarBio Therapeutics is a cell therapy company developing curative treatments for incurable diseases using cells. We have a profound knowledge on stem cells, how to cultivate, differentiate, scale and develop them as therapeutic agents to transform the life of patients with severe illnesses. We acknowledge the great potential of this platform to address many conditions. However, we are focusing ou efforts on two diseases: Heart Failure and Rett Syndrome. If you want to know more about how we do this, dont hesitate to contact us. LizarBio Therapeutics: curing incurable diseases using cells
5
Total investors
0
Early stage
5
Mid stage
0
Late stage
2013
Founded

Investors

5 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Brazil
4
China
1
Investor activity2016–2018 · investors recorded per year
2016420181
Recent (last 2y)Earlier
Frequently asked questions
Who invested in LizarBio Therapeutics?
LizarBio Therapeutics has 5 investors on record on gritt.io, 5 mid-stage.
When did LizarBio Therapeutics last raise funding?
The most recent investment in LizarBio Therapeutics recorded on gritt.io was in December 2018.
When was LizarBio Therapeutics founded?
LizarBio Therapeutics was founded in 2013.
What industry is LizarBio Therapeutics in?
LizarBio Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is LizarBio Therapeutics based?
LizarBio Therapeutics is headquartered in São Paulo, Brazil.